News

23 November

Health Action International Launches Programme to Improve Snakebite Situation in Kenya

23 November

HAI Snakebite Programme – Kenya

22 November

Health Action International Statement on World Health Organization’s General Programme of Work

21 November

Recommendations on a New Model for the Provision of Scientific Advice

13 November

HAI Consultation Response on World Health Organization’s 13th General Programme of Work (GPW13)

6 November

Joint Letter to Jeremy Hunt – Environmental Pollution at Pharma Factories

10 October

SRH Commodities: Measuring Prices, Availability & Affordability (Methodology & Data Entry Manual)

13 September

Recommendations to Strengthen WHO EURO Member State Collaboration on Improving Access to Medicines

25 July

Joint Letter to OECD on Sustainable Access to Innovative Therapies

5 July

Pharmaceutical Promotion in Medical and Pharmacy Education in The Netherlands: Readiness for Curriculum Change

20 June

Scenario 6: Sustainable Europe for Its Citizens

12 June

HAI & Global Snakebite Initiative Applaud WHO’s Adoption of Snakebite Envenoming as Top-level Neglected Tropical Disease

6 June

Media Release: Health Action International Commend Decision By World Health Organization Not To Include Long-Acting Analogue Insulins On The Essential Medicines List

6 June

Joint Letter to Jean-Claude Juncker: EU Health Collaboration is Crucial for Europe’s Future

23 May

European Union Leadership Critical for Affordable & Responsible Antibiotic R&D

19 May

Response to Health Canada on Release of Clinical Data

18 May

Proposed Changes to EMA’s Access to Documents Policy Fall Short on Proactive Disclosure

17 May

Joint Response to EMA Consultation on Its Access to Documents Policy

4 May

Joint Letter to World Health Assembly Delegates | We must delink research and development costs from cancer medicine prices

28 April

Response to OECD Online Consultation ‘Sustainable access to innovative therapies’

7 April

Statement to the WHO Expert Committee on Selection and Use of Essential Medicines

6 April

ACCISS Study Report | Biosimilar Insulin Regulatory Profile

5 April

2016 Annual Report & Financial Statements

29 March

Report | The Sun Shines on Europe: transparency of financial relationships in the healthcare sector

23 March

ACCISS Study Report | Access to Insulin: Current Challenges and Constraints

20 March

Position Statement: TACD Positive Consumer Agenda – New Rules for the Global Economy

7 March

Media Release: Health Action International start een publiekscampagne tegen stijgende medicijnprijzen

7 March

Media Release: Soaring Medicine Prices the Target Of New Public Campaign Ahead Of 15 March Election

3 March

Media Statement: European Parliament Hits Target in Recommendations for Improving Access to Medicines

7 February

Conference Report: Clinical Drug Trials